India Pacemaker Market is flourishing due to the rising prevalence of cardiovascular diseases, growing geriatric population, increasing life expectancy, and government’s supportive reimbursement ...

Boston Scientific Corporation BSX is gaining traction in the international regions. New regulatory approvals and accretive ...

Janus Henderson Investors, an investment management company, released its “Janus Henderson Enterprise Fund” second quarter ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Boston Scientific (BSX – Research Report) yesterday and set a price target of $87.00. The company’s shares closed last Friday at $83.35.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Shares of Boston Scientific Corp. BSX inched 0.10% higher to $84.00 Monday, on what proved to be an all-around positive ...

Boston Scientific is renowned for its cutting-edge technologies, such as stents, pacemakers, and endoscopic tools, which enhance patient care and improve clinical outcomes. The company generates ...

UPDATE: Sept. 17, 2024: Boston Scientific said Tuesday that it has closed its acquisition of Silk Road Medical, completing the deal three months after announcing the proposal. The deal includes a ...

MARLBOROUGH, Mass., Sept. 17, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Silk Road Medical, Inc. (Nasdaq: SILK), a medical ...

Boston Scientific announced its acquisition of ... This segment includes devices like pacemakers, implantable cardioverter defibrillators (ICDs), diagnostic and balloon catheters, 3D mapping ...

Boston Scientific Corporation (NYSE ... which were previously approved in 2019 for use with pacemakers and defibrillators. The INGEVITY+ Pacing Leads are designed to be placed inside the heart ...

(RTTNews) - Medical technology company Boston Scientific Corp. (BSX) announced Tuesday the close of its acquisition of medical device company Silk Road Medical, Inc. (SILK) for $27.50 per share in ...